Analyzing tumor deposits after stomach cancer surgery
Part of Cancer, Digestive system clinical trials.
This study looks at cancer cell deposits found in the area where the right and left stomach-supporting tissues meet, after surgery for stomach cancer. It may help doctors understand how cancer spreads and improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a confirmed type of stomach cancer called gastric adenocarcinoma.
- Your cancer is at a stage where it hasn't spread to nearby organs or far away (stages T2 to T4a, with or without lymph node involvement, but no distant spread).
- You are scheduled for a surgery called proximal gastrectomy with D2 lymph node removal and complete removal of stomach-supporting tissue (mesogastric excision).
- Your health status is good enough for surgery, as measured by the ASA score of I, II, or III.
- You have not had chemotherapy or radiation before this surgery, no previous upper belly surgery, and your BMI is under 30.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the importance of checking lymph nodes in the fatty tissue around the stomach during stomach cancer surgery. It helps doctors understand if examining these specific areas can improve treatment decisions.
This trial looks at how stomach cancer spreads to lymph nodes and other tissues behind the stomach during surgery. It may help doctors understand which patients need more extensive surgery.
This study looks at where cancer spreads in the short stomach area after total stomach removal surgery. It aims to understand lymph node and tumor deposits better to help guide future treatment decisions.
This study tracks a simple blood test to look for tiny traces of cancer DNA after stomach cancer surgery. It aims to see if this test can catch any cancer coming back early, so you can get treatment sooner.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This study keeps track of how people recover after surgery to remove the upper part of the stomach and nearby lymph nodes. It mainly helps doctors understand which surgical reconstruction methods work best and how patients do over time.
Hear when a new Gastric Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.